Curcuminoids rescue long-term potentiation impaired by amyloid peptide in rat hippocampal slices

Synapse

Volumn 65, Issue 7, 2011, Pages 572-582

  Ahmed, Touqeer ^a   Gilani, Anwarul Hassan ^a   Hosseinmardi, Narges ^b   Semnanian, Saeed ^b   Enam, Syed Ather ^a   Fathollahi, Yaghoub ^b  

^a AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Alzheimer's disease; Curcumin; Curcuminoids; Hippocampus; LTP; Memory

Indexed keywords

AMYLOID BETA PROTEIN; CURCUMIN; CURCUMINOID DERIVATIVE; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; TURMERIC; UNCLASSIFIED DRUG;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG MEGADOSE; DRUG STRUCTURE; HIPPOCAMPAL CA1 REGION; LONG TERM POTENTIATION; MALE; NERVE CELL EXCITABILITY; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; RAT; SPIKE WAVE;

AMYLOID BETA-PEPTIDES; ANIMALS; CURCUMIN; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; NEURONS; ORGAN CULTURE TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79953905604     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20876     Document Type: Article

References (47)

1. Aggarwal BB, Sung B. 2009. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol Sci 30: 85-94.
2. Ahmed T, Gilani AH. 2009. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease. Pharmacol Biochem Behav 91: 554-559.
3. Ahmed T, Enam SA, Gilani AH. 2010. Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease. Neuroscience 169: 1296-1306.
4. Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi AH, Khani M. 2003. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: A double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 28: 53-59.
5. Bala K, Tripathy BC, Sharma D. 2006. Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology 7: 81-89.
6. Baum L, Lam CW, Cheung SK, Kwok T, Lui V, Tsoh J, Lam L, Leung V, Hui E, Ng C, Woo J, Chiu HF, Goggins WB, Zee BC, Cheng KF, Fong CY, Wong A, Mok H, Chow MS, Ho PC, Ip SP, Ho CS, Yu XW, Lai CY, Chan MH, Szeto S, Chan IH, Mok V. 2008. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J Clin Psychopharmacol 28: 110-113.
7. Blennow K, de Leon MJ, Zetterberg H. 2006. Alzheimer's disease. Lancet 368: 387-403.
8. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY. 2001. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900.
9. Corson TW, Crews CM. 2007. Molecular understanding and modern application of traditional medicines: Triumphs and trials. Cell 130: 769-774.
10. Dairam A, Limson JL, Watkins GM, Antunes E, Daya S. 2007. Curcuminoids, curcumin, and demethoxycurcumin reduce lead-induced memory deficits in male Wistar rats. J Agric Food Chem 55: 1039-1044.
11. Dohare P, Garg P, Jain V, Nath C, Ray M. 2008. Dose dependence and therapeutic window for the neuroprotective effects of curcumin in thromboembolic model of rat. Behav Brain Res 193: 289-297.
12. Duke JA. 2002. Hand book of medicinal herbs. Boca Raton, FL: CRC Press.
13. ++ antagonist and specific butyrylcholinesterase inhibitory activity of dried ginger extract might explain its use in dementia. J Pharm Pharmacol 60: 1375-1383.
14. Gilani AH, Rahman AU. 2005. Trends in ethnopharmocology. J Ethnopharmacol 100: 43-49.
15. Gilani AH, Shah AJ, Ghayur MN, Majeed K. 2005. Pharmacological basis for the use of turmeric in gastrointestinal and respiratory disorders. Life Sci 76: 3089-3105.
16. Goel A, Kunnumakkara AB, Aggarwal BB. 2008. Curcumin as "Curecumin": From kitchen to clinic. Biochem Pharmacol 75: 787-809.
17. Gong B, Cao Z, Zheng P, Vitolo OV, Liu S, Staniszewski A, Moolman D, Zhang H, Shelanski M, Arancio O. 2006. Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell 126: 775-788.
18. Kapoor L. 1990. Handbook of ayurvedic medicinal plants. Boca Raton, FL: CRC Press.
19. Kim DS, Park SY, Kim JK. 2001. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from βA(1-42) insult. Neurosci Lett 303: 57-61.
20. Kim H, Park BS, Lee KG, Choi CY, Jang SS, Kim YH, Lee SE. 2005. Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem 53: 8537-8541.
21. Kumar P, Padi SS, Naidu PS, Kumar A. 2007. Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity. Methods Find Exp Clin Pharmacol 29: 19-25.
22. Lao CD, Ruffin MTt, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE. 2006. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6: 10.
23. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF. 1997. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia.North American EGb Study Group. JAMA 278: 1327-1332.
24. Li YC, Wang FM, Pan Y, Qiang LQ, Cheng G, Zhang WY, Kong LD. 2009. Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog Neuropsychopharmacol Biol Psychiatry 33: 435-449.
25. Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. 2001. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21: 8370-8377.
26. Lin R, Chen X, Li W, Han Y, Liu P, Pi R. 2008. Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: Blockage by curcumin. Neurosci Lett 440: 344-347.
27. Mahmmoud YA. 2007. Modulation of protein kinase C by curcumin; inhibition and activation switched by calcium ions. Br J Pharmacol 150: 200-208.
28. Martin SJ, Grimwood PD, Morris RG. 2000. Synaptic plasticity and memory: An evaluation of the hypothesis. Annu Rev Neurosci 23: 649-711.
29. Nadkarni K. 1986. Indian materia medica. Bombay: Popular Prakashan.
30. Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH. 2006. Curry consumption and cognitive function in the elderly. Am J Epidemiol 164: 898-906.
31. National Research Council. 1996. Guide for the care and use of laboratory animals. Washington, D.C.: National Academy Press.
32. Ono K, Hasegawa K, Naiki H, Yamada M. 2004. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 75: 742-750.
33. Raymond CR. 2007. LTP forms 1, 2 and 3: Different mechanisms for the "long" in long-term potentiation. Trends Neurosci 30: 167-175.
34. Roncarati R, Sestan N, Scheinfeld MH, Berechid BE, Lopez PA, Meucci O, McGlade JC, Rakic P, D'Adamio L. 2002. The γ-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling. Proc Natl Acad Sci USA 99: 7102-7107.
35. Salmanzadeh F, Fathollahi Y, Semnanian S, Shafizadeh M. 2003. Dependence on morphine impairs the induction of long-term potentiation in the CA1 region of rat hippocampal slices. Brain Res 965: 108-113.
36. Schmidt BM, Ribnicky DM, Lipsky PE, Raskin I. 2007. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol 3: 360-366.
37. Selkoe DJ. 2001. Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81: 741-766.
38. Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. 1998. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64: 353-356.
39. Sreejayan, Rao MN. 1994. Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 46: 1013-1016.
40. Tang H, Lu D, Pan R, Qin X, Xiong H, Dong J. 2009. Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats. Life Sci 85: 1-10.
41. Wang Q, Walsh DM, Rowan MJ, Selkoe DJ, Anwyl R. 2004. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J Neurosci 24: 3370-3378.
42. Wang R, Li YB, Li YH, Xu Y, Wu HL, Li XJ. 2008. Curcumin protects against glutamate excitotoxicity in rat cerebral cortical neurons by increasing brain-derived neurotrophic factor level and activating TrkB. Brain Res 1210: 84-91.
43. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM. 2005. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280: 5892-5901.
44. Zakharenko SS, Patterson SL, Dragatsis I, Zeitlin SO, Siegelbaum SA, Kandel ER, Morozov A. 2003. Presynaptic BDNF required for a presynaptic but not postsynaptic component of LTP at hippocampal CA1-CA3 synapses. Neuron 39: 975-990.
45. Zhang L, Fiala M, Cashman J, Sayre J, Espinosa A, Mahanian M, Zaghi J, Badmaev V, Graves MC, Bernard G, Rosenthal M. 2006. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J Alzheimers Dis 10: 1-7.
46. Zhang LJ, Wu CF, Meng XL, Yuan D, Cai XD, Wang QL, Yang JY. 2008. Comparison of inhibitory potency of three different curcuminoid pigments on nitric oxide and tumor necrosis factor production of rat primary microglia induced by lipopolysaccharide. Neurosci Lett 447: 48-53.
47. Zhao J, Zhao Y, Zheng W, Lu Y, Feng G, Yu S. 2008. Neuroprotective effect of curcumin on transient focal cerebral ischemia in rats. Brain Res 1229: 224-232.